BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 29329501)

  • 1. Sustained plasma hepcidin suppression and iron elevation by Anticalin-derived hepcidin antagonist in cynomolgus monkey.
    Hohlbaum AM; Gille H; Trentmann S; Kolodziejczyk M; Rattenstetter B; Laarakkers CM; Katzmann G; Christian HJ; Andersen N; Allersdorfer A; Olwill SA; Meibohm B; Audoly LP; Swinkels DW; van Swelm RPL
    Br J Pharmacol; 2018 Apr; 175(7):1054-1065. PubMed ID: 29329501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacodynamic Model of Hepcidin Regulation of Iron Homeostasis in Cynomolgus Monkeys.
    Krzyzanski W; Xiao JJ; Sasu B; Hinkle B; Perez-Ruixo JJ
    AAPS J; 2016 May; 18(3):713-27. PubMed ID: 26917226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First-in-human Phase I studies of PRS-080#22, a hepcidin antagonist, in healthy volunteers and patients with chronic kidney disease undergoing hemodialysis.
    Renders L; Budde K; Rosenberger C; van Swelm R; Swinkels D; Dellanna F; Feuerer W; Wen M; Erley C; Bader B; Sommerer C; Schaier M; Meurer K; Matis L
    PLoS One; 2019; 14(3):e0212023. PubMed ID: 30917125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-repulsive Guidance Molecule C (RGMc) Antibodies Increases Serum Iron in Rats and Cynomolgus Monkeys by Hepcidin Downregulation.
    Böser P; Seemann D; Liguori MJ; Fan L; Huang L; Hafner M; Popp A; Mueller BK
    AAPS J; 2015 Jul; 17(4):930-8. PubMed ID: 25896304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety, pharmacokinetics and pharmacodynamics of the anti-hepcidin Spiegelmer lexaptepid pegol in healthy subjects.
    Boyce M; Warrington S; Cortezi B; Zöllner S; Vauléon S; Swinkels DW; Summo L; Schwoebel F; Riecke K
    Br J Pharmacol; 2016 May; 173(10):1580-8. PubMed ID: 26773325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepcidin.
    Agarwal AK; Yee J
    Adv Chronic Kidney Dis; 2019 Jul; 26(4):298-305. PubMed ID: 31477260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoiesis-driven regulation of hepcidin in human red cell disorders is better reflected through concentrations of soluble transferrin receptor rather than growth differentiation factor 15.
    Fertrin KY; Lanaro C; Franco-Penteado CF; de Albuquerque DM; de Mello MR; Pallis FR; Bezerra MA; Hatzlhofer BL; Olbina G; Saad ST; da Silva Araújo A; Westerman M; Costa FF
    Am J Hematol; 2014 Apr; 89(4):385-90. PubMed ID: 24860871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepcidin-Induced Iron Deficiency Is Related to Transient Anemia and Hypoferremia in Kawasaki Disease Patients.
    Huang YH; Kuo HC; Huang FC; Yu HR; Hsieh KS; Yang YL; Sheen JM; Li SC; Kuo HC
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27187366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepcidin and diabetes are independently related with soluble transferrin receptor levels in chronic dialysis patients.
    Belo L; Rocha S; Valente MJ; Coimbra S; Catarino C; Bronze-da-Rocha E; Rocha-Pereira P; do Sameiro-Faria M; Oliveira JG; Madureira J; Fernandes JC; Miranda V; Santos-Silva A
    Ren Fail; 2019 Nov; 41(1):662-672. PubMed ID: 31296086
    [No Abstract]   [Full Text] [Related]  

  • 10. Iron status in patients with pyruvate kinase deficiency: neonatal hyperferritinaemia associated with a novel frameshift deletion in the PKLR gene (p.Arg518fs), and low hepcidin to ferritin ratios.
    Mojzikova R; Koralkova P; Holub D; Zidova Z; Pospisilova D; Cermak J; Striezencova Laluhova Z; Indrak K; Sukova M; Partschova M; Kucerova J; Horvathova M; Divoky V
    Br J Haematol; 2014 May; 165(4):556-63. PubMed ID: 24533562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of anti-hepcidin monoclonal antibody Ab 12B9m and hepcidin in cynomolgus monkeys.
    Xiao JJ; Krzyzanski W; Wang YM; Li H; Rose MJ; Ma M; Wu Y; Hinkle B; Perez-Ruixo JJ
    AAPS J; 2010 Dec; 12(4):646-57. PubMed ID: 20737261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepcidin independent iron recycling in a mouse model of β-thalassaemia intermedia.
    Frazer DM; Wilkins SJ; Mirciov CS; Dunn LA; Anderson GJ
    Br J Haematol; 2016 Oct; 175(2):308-317. PubMed ID: 27410488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baseline hepcidin measurement in the differential diagnosis of anaemia for elderly patients and its correlation with the increment of transferrin saturation following an oral iron absorption test.
    Wolff F; De Breucker S; Pepersack T; Compté N; Mélot C; Gulbis B; Cotton F
    Clin Chem Lab Med; 2018 Dec; 57(2):250-258. PubMed ID: 30055098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of oral supplementation of iron on hepcidin blood concentrations among non-anaemic female blood donors: a randomized controlled trial.
    Waldvogel S; Rochat B; Peduzzi D; Vaucher P; Tissot JD; Favrat B
    Vox Sang; 2016 Feb; 110(2):166-71. PubMed ID: 26394360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A first-in-human phase 1 study of a hepcidin monoclonal antibody, LY2787106, in cancer-associated anemia.
    Vadhan-Raj S; Abonour R; Goldman JW; Smith DA; Slapak CA; Ilaria RL; Tiu RV; Wang X; Callies S; Cox J; Tuttle JL; Lau YK; Roeland EJ
    J Hematol Oncol; 2017 Mar; 10(1):73. PubMed ID: 28327200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum hepcidin-25 in comparison to biochemical markers and hematological indices for the differentiation of iron-restricted erythropoiesis.
    Thomas C; Kobold U; Thomas L
    Clin Chem Lab Med; 2011 Feb; 49(2):207-13. PubMed ID: 21143009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum hepcidin measured with an improved ELISA correlates with parameters of iron metabolism in patients with myelodysplastic syndrome.
    Zipperer E; Post JG; Herkert M; Kündgen A; Fox F; Haas R; Gattermann N; Germing U
    Ann Hematol; 2013 Dec; 92(12):1617-23. PubMed ID: 23842708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A fully human anti-hepcidin antibody modulates iron metabolism in both mice and nonhuman primates.
    Cooke KS; Hinkle B; Salimi-Moosavi H; Foltz I; King C; Rathanaswami P; Winters A; Steavenson S; Begley CG; Molineux G; Sasu BJ
    Blood; 2013 Oct; 122(17):3054-61. PubMed ID: 23945155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LC-MS/MS method for hepcidin-25 measurement in human and mouse serum: clinical and research implications in iron disorders.
    Lefebvre T; Dessendier N; Houamel D; Ialy-Radio N; Kannengiesser C; Manceau H; Beaumont C; Nicolas G; Gouya L; Puy H; Karim Z
    Clin Chem Lab Med; 2015 Sep; 53(10):1557-67. PubMed ID: 25781546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepcidin: Homeostasis and Diseases Related to Iron Metabolism.
    Reichert CO; da Cunha J; Levy D; Maselli LMF; Bydlowski SP; Spada C
    Acta Haematol; 2017; 137(4):220-236. PubMed ID: 28514781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.